Sort
21,281 grants matching “influenza”
Immunobiology of the DsrA protein of H. ducreyi
$240,241Christopher Elkins · Univ Of North Carolina Chapel Hill · U19 · FY2010 · AI
BIOPHYSICS OF PROTEIN-MEDIATED MEMBRANE FUSION
$240,240Rush University Medical Center · R01 · FY2001 · GM
BIOPHYSICS OF PROTEIN-MEDIATED MEMBRANE FUSION
$240,240Rush University Medical Center · R01 · FY2003 · GM
BIOPHYSICS OF PROTEIN-MEDIATED MEMBRANE FUSION
$240,240Rush University Medical Center · R01 · FY2002 · GM
BIOLOGY OF H INFLUENZAE HIA AND HSF ADHESINS
$240,174Washington University · R01 · FY2001 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - COVAIL DMID #22-0004
$240,086David S Stephens · Emory University · UM1 · FY2022 · AI
Sustaining Influenza Surveillance Networks and Response to Seasonal
$240,000Maria Eugenia Jimenez-Corona · Fundacion Mexico Estados Unidos/Cienca · U51 · FY2014 · IP
INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINES
$240,000Tran Dacphu · General Department/ Preventive Medicine · U51 · FY2013 · IP
Sustaining Influenza Surveillance Networks and Response to Seasonal
$240,000Khatuna Zakhashvili · National Center/Disease Ctrl/Med Stats · U51 · FY2013 · IP
DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID-19 ONGOING MONITORING (COMMUNITY)
$240,000Luca Foschini · Evidation Health, Inc. · N01 · FY2020 · CA
Therapeutic efficacy of favipiravir against henipavirus infections
$240,000Alexander Niclas Freiberg · University Of Texas Med Br Galveston · R21 · FY2021 · AI
Enhanced immunogenicity and protection study of lipid modified protein vaccine candidates of Nontypeable Haemophilus influenzae
$240,000Ravinder Kaur · Rochester General Hospital (Ny) · R21 · FY2020 · AI
Utilizing a novel hamster model to determine neurologic and behavioral abnormalities of offspring from mothers infected with SARS-CoV-2
$240,000Kenneth Steven Plante · University Of Texas Med Br Galveston · R21 · FY2025 · NS
Racial Disparities, Influenza Like Illness and the Association between Short-term Exposure to Ambient Air Pollution and Cardiovascular Outcomes
$240,000Amelia K Boehme · Columbia University Health Sciences · R21 · FY2017 · MD
Silencer-enhancer transition dysregulates interleukin-6 in mucosal epithelial cell plasticity
$240,000Jun Yang · University Of Texas Med Br Galveston · R21 · FY2024 · AI
Ecology-Based Risk Assessment and Early Warning for HPAI in Asia
$240,000Xiangming Xiao · University Of Oklahoma · R01 · FY2009 · TW
INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINES
$240,000Tran Dacphu · General Department/ Preventive Medicine · U51 · FY2014 · IP
IL-10 producing neutrophils during respiratory virus infection
$240,000Carolina B. Lopez · University Of Pennsylvania · R21 · FY2015 · AI
SURVEILLANCE AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA BY NATIONAL
$240,000Aishath Abdulla · Health Protection Agency · U51 · FY2014 · IP
The Mechanisms of IFITM-Mediated Restriction
$239,996I-Chueh Huang · University Of California Riverside · R00 · FY2013 · AI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases
$239,961Shawn Iadonato · Kineta, Inc. · N01 · FY2017 · AI
Inference for interacting pathogens with mechanistic and phenomenological models
$239,880Nicholas G Reich · University Of Massachusetts Amherst · R21 · FY2016 · AI
Epitope focusing to the receptor binding motif for a universal coronavirus vaccine
$239,867Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2021 · AI
TYPE I INTERFERON REULATION OF IMMUNOPATHOLOGY IN INFLUENZA PNEUMONIA
$239,854Richard I Enelow · Dartmouth College · P20 · FY2009 · RR
Development of MMP14-laden exosomes as a novel anti-SARS-CoV-2 therapy
$239,850Kyuyeon Han · University Of Illinois At Chicago · R21 · FY2024 · AI